Trgovina vTv Therapeutics Inc. - VTVT CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.06 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 0.76 |
Odpri* | 0.74 |
Enoletna sprememba* | 19.35% |
Dnevni razpon* | 0.73 - 0.76 |
Razpon 52 wk | 0.38-1.40 |
Povprečni obseg (10 dni) | 66.30K |
Povprečni obseg (3 meseci) | 2.25M |
Tržna kapitalizacija | 81.05M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 104.58M |
Prihodki | 2.02M |
EPS | -0.26 |
Dividenda (donosnost v %) | N/A |
Beta | -1.17 |
Datum naslednjega zaslužka | May 10, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Mar 22, 2023 | 0.73 | -0.01 | -1.35% | 0.74 | 0.76 | 0.73 |
Mar 21, 2023 | 0.76 | 0.02 | 2.70% | 0.74 | 0.76 | 0.74 |
Mar 20, 2023 | 0.74 | 0.01 | 1.37% | 0.73 | 0.75 | 0.73 |
Mar 17, 2023 | 0.74 | 0.00 | 0.00% | 0.74 | 0.75 | 0.72 |
Mar 16, 2023 | 0.77 | 0.01 | 1.32% | 0.76 | 0.77 | 0.75 |
Mar 15, 2023 | 0.77 | 0.00 | 0.00% | 0.77 | 0.79 | 0.77 |
Mar 14, 2023 | 0.77 | 0.03 | 4.05% | 0.74 | 0.77 | 0.74 |
Mar 13, 2023 | 0.74 | 0.04 | 5.71% | 0.70 | 0.76 | 0.68 |
Mar 10, 2023 | 0.69 | -0.08 | -10.39% | 0.77 | 0.77 | 0.67 |
Mar 9, 2023 | 0.78 | -0.04 | -4.88% | 0.82 | 0.82 | 0.77 |
Mar 8, 2023 | 0.82 | -0.08 | -8.89% | 0.90 | 0.90 | 0.81 |
Mar 7, 2023 | 0.86 | -0.01 | -1.15% | 0.87 | 0.92 | 0.85 |
Mar 6, 2023 | 0.91 | 0.02 | 2.25% | 0.89 | 0.92 | 0.79 |
Mar 3, 2023 | 0.76 | -0.01 | -1.30% | 0.77 | 0.77 | 0.75 |
Mar 2, 2023 | 0.77 | -0.04 | -4.94% | 0.81 | 0.81 | 0.76 |
Mar 1, 2023 | 0.79 | 0.00 | 0.00% | 0.79 | 0.80 | 0.78 |
Feb 28, 2023 | 0.79 | 0.04 | 5.33% | 0.75 | 0.79 | 0.75 |
Feb 27, 2023 | 0.75 | -0.04 | -5.06% | 0.79 | 0.80 | 0.75 |
Feb 24, 2023 | 0.78 | -0.01 | -1.27% | 0.79 | 0.79 | 0.78 |
Feb 23, 2023 | 0.82 | -0.01 | -1.20% | 0.83 | 0.83 | 0.81 |
vTv Therapeutics Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Skupni prihodki | 4.005 | 6.414 | 2.764 | 12.434 | 0.291 |
Prihodki | 4.005 | 6.414 | 2.764 | 12.434 | 0.291 |
Celotni odhodki iz poslovanja | 25.667 | 18.266 | 23.656 | 32.258 | 50.973 |
Celotna prodaja/splošni/upravni stroški Odhodki | 11.443 | 7.251 | 8.537 | 9.223 | 11.333 |
Raziskave in razvoj | 12.624 | 11.015 | 15.119 | 23.035 | 39.64 |
Prihodki iz poslovanja | -21.662 | -11.852 | -20.892 | -19.824 | -50.682 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.011 | -0.68 | -1.774 | -3.229 | -2.975 |
Drugo, neto | 4.057 | -0.27 | 0.828 | -0.592 | -0.19 |
Čisti dobiček pred obdavčitvijo | -17.616 | -12.802 | -21.838 | -23.645 | -53.847 |
Čisti dobiček po davkih | -17.731 | -12.802 | -21.938 | -23.845 | -48.8 |
Manjšinski delež | 4.744 | 4.303 | 8.894 | 15.934 | 38.503 |
Čisti dobiček pred dodatnimi postavkami | -12.987 | -8.499 | -13.044 | -7.911 | -10.297 |
Čisti dobiček | -12.987 | -8.499 | -13.044 | -7.911 | -16.144 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -12.987 | -8.499 | -17.913 | -8.65 | -10.297 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -12.987 | -8.499 | -17.913 | -8.65 | -16.144 |
Popravljen čisti dobiček | -12.987 | -8.499 | -17.913 | -8.65 | -16.144 |
Popravljene ponderirane povprečne delnice | 60.7326 | 47.1379 | 30.292 | 12.4492 | 9.69325 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.21384 | -0.1803 | -0.59134 | -0.69482 | -1.06229 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
Popravljen normalizirani dobiček na enoto čistega dobička | -0.19671 | -0.1803 | -0.59134 | -0.69482 | -1.06229 |
Skupaj izredne postavke | -5.847 | ||||
Total Adjustments to Net Income | 0 | -4.869 | -0.739 | ||
Nenavadni odhodki (prihodki) | 1.6 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 2 | 0.009 | 3 | 0.009 | 0.987 |
Prihodki | 2 | 0.009 | 3 | 0.009 | 0.987 |
Celotni odhodki iz poslovanja | 8.481 | 11.118 | 4.603 | 4.679 | 5.267 |
Celotna prodaja/splošni/upravni stroški Odhodki | 5.348 | 5.716 | 2.221 | 2.242 | 2.164 |
Raziskave in razvoj | 3.133 | 5.402 | 2.382 | 2.437 | 3.103 |
Prihodki iz poslovanja | -6.481 | -11.109 | -1.603 | -4.67 | -4.28 |
Prihodki (odhodki) od obresti, neto Neoperativni | -0.001 | -0.006 | -0.006 | 0 | 0.001 |
Drugo, neto | -2.742 | 1.632 | 0.244 | 3.829 | -1.648 |
Čisti dobiček pred obdavčitvijo | -9.224 | -9.483 | -1.365 | -0.841 | -5.927 |
Čisti dobiček po davkih | -9.424 | -9.483 | -1.465 | -0.841 | -5.942 |
Manjšinski delež | 2.417 | 2.432 | 0.378 | 0.233 | 1.701 |
Čisti dobiček pred dodatnimi postavkami | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
Čisti dobiček | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
Popravljen čisti dobiček | -7.007 | -7.051 | -1.087 | -0.608 | -4.241 |
Popravljene ponderirane povprečne delnice | 66.9428 | 66.719 | 61.0733 | 58.6151 | 56.4725 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.10467 | -0.10568 | -0.0178 | -0.01037 | -0.0751 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.10467 | -0.10568 | -0.0178 | -0.01037 | -0.0751 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 15.621 | 7.215 | 2.838 | 3.473 | 20.362 |
Denarna sredstva in kratkoročne naložbe | 13.415 | 5.747 | 1.777 | 1.683 | 11.758 |
Denarna sredstva in ustrezniki | 13.415 | 5.747 | 1.777 | 1.683 | 11.758 |
Celotne terjatve, neto | 0.057 | 0.158 | 0.005 | 0 | 8 |
Accounts Receivable - Trade, Net | 0.057 | 0.158 | 0.005 | 0 | 8 |
Prepaid Expenses | 1.914 | 0.939 | 0.806 | 0.666 | 0.442 |
Total Assets | 25.474 | 14.789 | 9.266 | 8.559 | 27.917 |
Property/Plant/Equipment, Total - Net | 0.68 | 0.849 | 1.004 | 0.07 | 0.283 |
Property/Plant/Equipment, Total - Gross | 0.985 | 1.065 | 1.152 | 8.501 | 9.399 |
Accumulated Depreciation, Total | -0.305 | -0.216 | -0.148 | -8.431 | -9.116 |
Other Long Term Assets, Total | 0 | 2.944 | 2.536 | 4.792 | |
Total Current Liabilities | 8.498 | 6.39 | 13.381 | 18.837 | 26.929 |
Accounts Payable | 1.876 | 1.925 | 2.232 | 2.899 | 2.269 |
Payable/Accrued | |||||
Accrued Expenses | 6.331 | 4.35 | 4.946 | 4.803 | 11.632 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.035 | 0.031 | 0.031 | 1.752 | 8.757 |
Total Liabilities | 35.214 | 94.891 | 58.289 | 91.412 | 178.964 |
Total Long Term Debt | 0 | 0 | 0 | 6.33 | 15.316 |
Long Term Debt | 0 | 6.33 | 15.316 | ||
Minority Interest | 24.962 | 83.895 | 40.183 | 62.482 | 131.44 |
Other Liabilities, Total | 1.754 | 4.606 | 4.725 | 3.763 | 5.279 |
Total Equity | -9.74 | -80.102 | -49.023 | -82.853 | -151.047 |
Common Stock | 0.901 | 0.773 | 0.641 | 0.435 | 0.329 |
Additional Paid-In Capital | 238.193 | 209.161 | 183.858 | 150.595 | 127.682 |
Retained Earnings (Accumulated Deficit) | -248.834 | -290.036 | -233.522 | -233.883 | -279.058 |
Total Liabilities & Shareholders’ Equity | 25.474 | 14.789 | 9.266 | 8.559 | 27.917 |
Total Common Shares Outstanding | 90.0366 | 77.1449 | 64.0127 | 43.4413 | 32.8125 |
Other Current Assets, Total | 0.235 | 0.371 | 0.25 | 1.124 | 0.162 |
Long Term Investments | 9.173 | 6.725 | 2.48 | 2.48 | 2.48 |
Current Port. of LT Debt/Capital Leases | 0.256 | 0.084 | 6.172 | 9.383 | 4.271 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 13.612 | 15.621 | 22.171 | 11.272 | 9.221 |
Denarna sredstva in kratkoročne naložbe | 12.138 | 13.415 | 19.566 | 10.835 | 8.449 |
Denarna sredstva in ustrezniki | 12.138 | 13.415 | 19.566 | 10.835 | 8.449 |
Celotne terjatve, neto | 0.057 | 0.057 | 0.928 | 0 | 0.002 |
Accounts Receivable - Trade, Net | 0.057 | 0.057 | 0.928 | 0 | 0.002 |
Prepaid Expenses | 1.387 | 2.049 | 1.574 | 0.313 | 0.71 |
Other Current Assets, Total | 0.03 | 0.1 | 0.103 | 0.124 | 0.06 |
Total Assets | 20.185 | 25.474 | 31.434 | 21.66 | 16.754 |
Property/Plant/Equipment, Total - Net | 0.634 | 0.68 | 0.724 | 0.766 | 0.808 |
Long Term Investments | 5.939 | 9.173 | 8.539 | 9.622 | 6.725 |
Total Current Liabilities | 12.7 | 8.498 | 5.51 | 5.059 | 5.162 |
Payable/Accrued | 12.474 | 8.023 | 4.663 | 4.855 | 4.965 |
Accrued Expenses | 0.191 | 0.184 | 0.176 | 0.169 | 0.162 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 0.256 | 0.636 | 0 | 0 |
Other Current Liabilities, Total | 0.035 | 0.035 | 0.035 | 0.035 | 0.035 |
Total Liabilities | 28.278 | 35.214 | 52.979 | 69.483 | 73.029 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 14.367 | 24.962 | 44.61 | 60.19 | 62.647 |
Other Liabilities, Total | 1.211 | 1.754 | 2.859 | 4.234 | 5.22 |
Total Equity | -8.093 | -9.74 | -21.545 | -47.823 | -56.275 |
Common Stock | 0.901 | 0.901 | 0.897 | 0.834 | 0.808 |
Additional Paid-In Capital | 238.669 | 238.193 | 236.557 | 224.457 | 217.647 |
Retained Earnings (Accumulated Deficit) | -247.663 | -248.834 | -258.999 | -273.114 | -274.73 |
Total Liabilities & Shareholders’ Equity | 20.185 | 25.474 | 31.434 | 21.66 | 16.754 |
Total Common Shares Outstanding | 90.0366 | 90.0366 | 89.565 | 83.2878 | 80.6658 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -17.731 | -12.802 | -21.938 | -23.845 | -54.647 |
Denarna sredstva iz poslovanja | -19.308 | -18 | -23.018 | -26.856 | -44.56 |
Denarna sredstva iz poslovanja | 0.089 | 0.094 | 0.039 | 0.218 | 0.197 |
Nedenarne postavke | -1.701 | -2.586 | 0.935 | 4.316 | 4.853 |
Denarna sredstva Plačane obresti | 0.011 | 0.623 | 1.295 | 2.276 | 2.064 |
Spremembe v obratnem kapitalu | 0.035 | -2.706 | -2.054 | -7.545 | 5.037 |
Denarna sredstva pri naložbenju | 0 | 0 | 0.242 | 0.007 | -0.025 |
Kapitalski izdatki | 0 | 0 | -0.07 | -0.005 | -0.057 |
Celotne druge postavke denarnih tokov pri naložbenju | 0 | 0 | 0.312 | 0.012 | 0.032 |
Denarna sredstva pri financiranju | 26.976 | 19.47 | 22.87 | 16.612 | 7.5 |
Postavke denarnega toka pri financiranju | 0 | 0 | |||
Izdaja (odplačilo) delnic, neto | 26.804 | 24.426 | 32.943 | 21.5 | 0 |
Izdaja (odplačilo) dolga, neto | 0.172 | -4.956 | -10.073 | -4.888 | 7.5 |
Neto sprememba denarnih sredstev | 7.668 | 1.47 | 0.094 | -10.237 | -37.085 |
Cash Taxes Paid | 0.115 | 0 | 0.1 | 1 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -9.424 | -17.731 | -8.248 | -6.783 | -5.942 |
Cash From Operating Activities | -1.021 | -19.308 | -12.891 | -9.297 | -5.299 |
Cash From Operating Activities | 0.023 | 0.089 | 0.067 | 0.045 | 0.023 |
Non-Cash Items | 3.218 | -1.701 | -1.063 | -1.292 | 2.084 |
Changes in Working Capital | 5.162 | 0.035 | -3.647 | -1.267 | -1.464 |
Cash From Financing Activities | -0.256 | 26.976 | 26.71 | 14.385 | 8.001 |
Issuance (Retirement) of Stock, Net | 0 | 26.804 | 26.158 | 14.469 | 8.085 |
Issuance (Retirement) of Debt, Net | -0.256 | 0.172 | 0.552 | -0.084 | -0.084 |
Net Change in Cash | -1.277 | 7.668 | 13.819 | 5.088 | 2.702 |
Cash From Investing Activities | 0 | ||||
Capital Expenditures | 0 | ||||
Other Investing Cash Flow Items, Total | 0 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
MacAndrews & Forbes Holdings, Inc. | Holding Company | 44.9246 | 36606212 | 87000 | 2022-05-31 | LOW |
G42 Investments AI Holdings RSC, Ltd. | Corporation | 12.7465 | 10386274 | 10386274 | 2022-05-31 | LOW |
Medpace Investors, L.L.C. | Corporation | 6.6241 | 5397529 | 5397529 | 2022-08-16 | LOW |
Samsara BioCapital, LLC | Venture Capital | 2.0072 | 1635509 | 0 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.1531 | 939623 | 653 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.3551 | 289347 | -653 | 2022-12-31 | LOW |
Veritable, L.P. | Investment Advisor/Hedge Fund | 0.2981 | 242937 | 222032 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.1654 | 134745 | 0 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 0.0786 | 64078 | -13261 | 2022-12-31 | HIGH |
Fry (John Anthony) | Individual Investor | 0.0749 | 61000 | 61000 | 2022-11-29 | LOW |
Nelson (Rich S) | Individual Investor | 0.0736 | 60000 | 0 | 2022-04-04 | |
HBKS Wealth Advisors | Investment Advisor | 0.0708 | 57694 | 57694 | 2022-12-31 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.0659 | 53660 | -185 | 2022-12-31 | LOW |
Citadel Advisors LLC | Hedge Fund | 0.06 | 48860 | 15848 | 2022-12-31 | HIGH |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.0498 | 40577 | 0 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.0467 | 38052 | 5667 | 2022-12-31 | HIGH |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.041 | 33442 | 0 | 2022-12-31 | LOW |
Simon Quick Advisors, LLC | Investment Advisor | 0.0368 | 30000 | 0 | 2022-12-31 | MED |
Bridgeway Capital Management, LLC | Investment Advisor | 0.0332 | 27018 | 0 | 2022-12-31 | LOW |
Kozlov (Hersh) | Individual Investor | 0.0307 | 25000 | 0 | 2022-04-04 |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
vTv Therapeutics Inc. Company profile
O družbi vTv Therapeutics Inc.
vTv Therapeutics Inc. je farmacevtsko podjetje v klinični fazi, ki se ukvarja z odkrivanjem in razvojem zdravil z majhnimi molekulami, ki se dajejo peroralno. Razvija program za zdravljenje sladkorne bolezni tipa I TTP399 in psoriaze HPP737. TTP399 je majhna molekula, ki se daje peroralno, jetrni selektivni aktivator glukokinase (GKA) v razvoju, potencialni peroralni antidiabetik za zdravljenje sladkorne bolezni tipa I. TTP399 je zaključil študijo SimpliciT-I, študijo faze II pri bolnikih s sladkorno boleznijo tipa I kot dodatek k zdravljenju z insulinom. Družba izvaja tudi študijo faze I z večkratnim naraščajočim odmerkom HPP737, zaviralca fosfodiesteraze tipa IV, ki se daje peroralno, za oceno farmakokinetike, farmakodinamike, varnosti in prenašanja HPP737 pri zdravih prostovoljcih kot del svojega programa za zdravljenje psoriaze. TTP273 je peroralni agonist receptorjev glukagonu podobnega peptida I (GLP-1), ki se ocenjuje za zdravljenje sladkorne bolezni tipa II.
Industry: | Bio Therapeutic Drugs |
3980 Premier Dr
Suite 310
HIGH POINT
NORTH CAROLINA 27265
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com